CK

Chandramani Kumar Jha

Active Director Director DIN 07818245
DIN 07818245 First appointment May 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Chandramani Kumar Jha

Data last updated:

Chandramani Kumar Jha is a Director at Sangus Life Science Private Limited (since 2017). The company operates in Pharma. Sangus Life Science Private Limited reported revenue of ₹8 Lakh (FY 2022).

DIN 07818245
Primary Designation Director
Industry Pharma
First Appointment 10 May 2017
Oldest Company Age 9 yrs
Largest company Sangus Life Science Private Limited · ₹8 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sangus Life Science Private Limited U24239BR2017PTC034534
Director10 May 20172017₹8 Lakh (FY 2022)Active

Board colleagues of Chandramani Kumar Jha

NameDINCompanyDesignation
Shilpi Kumari07818246Sangus Life Science Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sangus Life Science Private Limited
Premium access

Shareholding and investment profile for Chandramani Kumar Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandramani Kumar Jha

Chandramani Kumar Jha currently holds 1 directorship: Sangus Life Science Private Limited (Director, since 10 May 2017, revenue ₹8 Lakh (FY 2022)).

Chandramani Kumar Jha was first appointed on 10 May 2017 as Director at Sangus Life Science Private Limited.

The current boards of Chandramani Kumar Jha's companies include Shilpi Kumari (Sangus Life Science Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available